Articles from Biotech Insider

Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
Issued on behalf of GT Biopharma, Inc. (Nasdaq: GTBP)
By Biotech Insider · Via GlobeNewswire · June 8, 2026
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
Issued on behalf of Conexeu Sciences Inc.
By Biotech Insider · Via GlobeNewswire · May 27, 2026